A stunning reversal by the nation’s top health regulator could reshape how America confronts toxic substances in everyday products. The Food and Drug Administration appears ready to abandon a long-awaited rule that would have forced cosmetic companies to test talc-based products for traces of asbestos—a deadly mineral tied to cancer. For public health advocates, this decision feels like a step backward just as real progress seemed possible.
Talc, a soft mineral valued for its smooth texture, is found in countless products—makeup, powders, medications, and even food. The proposed rule aimed to ensure that talc used in these products was free from asbestos contamination. Yet, despite the obvious risks, the new administration under Health Secretary Robert F. Kennedy Jr., a central figure in the "Make America Healthy Again" (MAHA) movement, has signaled its intent to pull the plug. Ironically, the movement’s stated mission is to purge toxins from goods that Americans use daily. So why block a rule designed to do exactly that?
Health advocates are outraged. “Nothing could make America less healthy than allowing a known carcinogen in cosmetics,” argued Scott Faber, a senior policy official at the nonprofit Environmental Working Group. The organization has long pushed for tougher restrictions on talc testing. Faber added that reversing a measure that merely required testing for asbestos makes little sense in a country where tens of thousands die each year from asbestos-related diseases.
The FDA hasn’t issued a formal press release or public statement explaining its decision. Instead, a notice quietly appeared in the Federal Register, citing “good cause” to withdraw the proposal. The document referenced concerns about potential “unintended consequences” for pharmaceutical manufacturers—a phrase many interpret as code for industry opposition. In short, pressure from drugmakers may have tipped the scales.
For context, asbestos refers to a group of six naturally occurring minerals once prized for their resistance to heat and fire. But no level of exposure is considered safe. It is outlawed in more than 50 nations, yet still lingers in certain U.S. imports and products. Studies estimate that asbestos exposure kills around 40,000 Americans each year—making opposition to simple safety testing all the more baffling.
Records show that cosmetic companies have known about the risk of asbestos contamination since the 1950s. By the 1970s, the evidence was undeniable, yet the industry managed to persuade regulators to accept less sensitive testing methods—ones unable to detect all asbestos fibers. As a result, traces of asbestos have repeatedly been found in common products, including baby powder. This issue hit especially hard in Black communities, where talc-based powders were widely marketed and used.
The controversy reached a boiling point in 2020 when Johnson & Johnson halted U.S. sales of its talc-based baby powder after decades of criticism and nearly 38,000 lawsuits. The company has already paid billions in settlements and recently offered another $6.5 billion in a class-action deal over claims it knowingly exposed consumers to cancer risks. In the UK, about 3,000 women have also filed suit, accusing the company of poisoning them.
Despite the overwhelming scientific consensus on asbestos’s dangers, regulating it has been a decades-long uphill battle. The Environmental Protection Agency’s 1989 attempt to outlaw most asbestos uses was overturned by a court just a few years later. Multiple administrations have wrestled with new bans ever since. The Biden administration had finalized one such ban before the Trump administration briefly reversed course—then reinstated it after legal and political pushback earlier this year.
The proposed cosmetics rule was part of the 2022 Cosmetics Modernization Act, which bundled asbestos testing requirements into a broader package of safety reforms. The FDA had already begun implementing the rule under Biden, but the incoming administration now appears determined to scrap it altogether.
The agency’s notice claims the withdrawal aligns with MAHA’s broader goals of rethinking how best to limit asbestos exposure. It states that regulators will revisit “the best means of addressing the issues” and explore future “standardized testing methods” that balance consumer safety with industry concerns. But many see this as a strategic delay rather than real reform.
Scott Faber did not mince words. “It’s tragic that someone who has spent much of his life fighting cancer-causing pollutants is now dismantling efforts to stop them,” he said of Robert F. Kennedy Jr. The remark underscores the strange political twist in which a self-branded health crusader now faces backlash for potentially endangering the very people he pledges to protect.
Here’s the real debate: Should government health agencies prioritize preventing corporate inconvenience—or preventing cancer? Are fears of “unintended consequences” reason enough to roll back public safety protections? Share your thoughts below—does this decision make sense, or does it expose deeper problems in how America regulates toxic substances?
